INC Research Named "Best CRO" at the Triangle Business Journal Life Sciences Awards
(Thomson Reuters ONE) -
Global CRO recognized for "breaking new ground" in life sciences research
Raleigh, N.C., May 31, 2013 - INC Research, LLC, a therapeutically focused
global clinical research organization (CRO) with a Trusted Process(®) for
delivering reliable results, has been named "Best CRO" at the inaugural Triangle
Business Journal Life Sciences Awards. The awards recognize both individuals and
research organizations that are breaking new ground in the life sciences field.
INC Research accepted the award at a ceremony held June 13 in Cary, N.C.
"The Research Triangle is a hotbed of clinical development and CRO activity with
multiple global organizations headquartered here," said Jamie Macdonald, Chief
Executive Officer at INC Research. "To be judged the best in the Triangle has
broader reach and global implications when a significant portion of your
competition is based here as well. This award is a reaffirmation of our
commitment to customers, our employees and the Research Triangle community."
The "Best CRO" award was open to the public or private clinical research
organizations within the Triangle area that "demonstrate the importance of their
work in the life sciences sector." CROs were evaluated based on their economic
contribution to the Triangle community through job creation and other economic
impacts.
In announcing the list of winning companies and individuals, Bryan Michael
Hamilton, Publisher of the Triangle Business Journal stated, "The life sciences
industry is fast-becoming the heartbeat of the Triangle economy. Our inaugural
list of winners reflects the power, influence and intellect present in our
communities within this sector."
Being named Best CRO at the Triangle Business Journal Life Sciences Awards is
the latest honor for INC Research. The Company also was recently recognized as
"Top CRO" in the CenterWatch 2013 Global Investigative Site Relationship Survey
when results were published May 1. The Company also has been recognized for
technological innovation, oncology investigator recruitment, consistent quality
delivery, data management innovation and for developing one of the top strategic
partnerships in the CRO industry.
About INC Research
INC Research is a therapeutically focused clinical research organization with a
high-performance reputation for conducting global clinical developmentprograms
of the highest integrity. Pharmaceutical and biotechnology companies look to us
for a complete range of customized Phase I to IV programs in all therapeutic
areas and patient populations (including pediatric and women's health). Our
Trusted Process® methodology and therapeutic foresight lead customers to better-
informed product development decisions, while our solid site relationships are a
critical success factor in delivering clinical trial results on time and on
budget. INC was ranked "Top CRO" by sites worldwide in the 2013 CenterWatch
Global Investigative Site Relationship Survey. INC Research is headquartered in
Raleigh, N.C. For more information, please visit www.incresearch.com or follow
us at (at)inc_research.
Contact: Lori Dorer, Media +1 (513) 345-1685
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: INC RESEARCH, LLC via Thomson Reuters ONE
[HUG#1709445]
Unternehmensinformation / Kurzprofil:
Datum: 13.06.2013 - 22:29 Uhr
Sprache: Deutsch
News-ID 269714
Anzahl Zeichen: 4014
contact information:
Town:
Raleigh
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 345 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"INC Research Named "Best CRO" at the Triangle Business Journal Life Sciences Awards"
steht unter der journalistisch-redaktionellen Verantwortung von
INC RESEARCH, LLC (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
